Neumora Therapeutics is trading at $0.47, down 5.64%, with no clear company-specific news identified to explain the October 5, 2026 decline.
- The investor-relations press-release page lists August 14, 2026, as the latest release; no October 5 announcement is shown.
- Market context was mixed: the Nasdaq was up 0.71%, while the Dow was down 0.24%. Trading volume or activity level was not available in the supplied data.